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VDAC1The voltage-dependent anion channel (VDAC), located at the outer mitochondria membrane (OMM), medi-
ates interactions between mitochondria and other parts of the cell by transporting anions, cations, ATP,
Ca2+, and metabolites. Substantial evidence points to VDAC1 as being a key player in apoptosis, regulating
the release of apoptogenic proteins frommitochondria, such as cytochrome c, and interacting with anti-apoptotic
proteins. Recently, we demonstrated that VDAC1 oligomerization is a general mechanism common to numerous
apoptogens acting via different initiating cascades and proposed that a protein-conducting channel formedwithin
a VDAC1 homo/hetero oligomer mediates cytochrome c release. However, the molecular mechanism responsible
for VDAC1 oligomerization remains unclear. Several studies have shown that mitochondrial Ca2+ is involved in
apoptosis induction and that VDAC1 possesses Ca2+-binding sites and mediates Ca2+ transport across the
OMM. Here, the relationship between the cellular Ca2+ level, [Ca2+]i, VDAC1 oligomerization and apoptosis was
studied. Decreasing [Ca2+]i using the cell-permeable Ca
2+ chelating reagent BAPTA-AM was found to inhibit
VDAC1 oligomerization and apoptosis, while increasing [Ca2+]i using Ca2+ ionophore resulted in VDAC1 oligo-
merization and apoptosis induction in the absence of apoptotic stimuli. Moreover, induction of apoptosis elevated
[Ca2+]i, concomitantly with VDAC1 oligomerization. AzRu-mediated inhibition of mitochondrial Ca
2+ transport
decreased VDAC1 oligomerization, suggesting that mitochondrial Ca2+ is required for VDAC1 oligomerization. In
addition, increased [Ca2+]i levels up-regulate VDAC1 expression. These results suggest that Ca2+ promotes
VDAC1 oligomerization via activation of a yet unknown signaling pathway or by increasing VDAC1 expression,
leading to apoptosis. This article is part of a Special Issue entitled: 12th European Symposium on Calcium.
© 2013 Published by Elsevier B.V.1. Introduction
Apart from their metabolic and apoptotic roles, mitochondria seques-
ter Ca2+ at the expense of energy [1]. Mitochondria thus serve as amajor
hubof cellular Ca2+homeostasis, fundamental for awide rangeof cellular
activities, such as control of oxidative phosphorylation [2,3], cell death
[4–6] and secretion [7].
To regulate cytosolic and mitochondrial Ca2+ concentrations, mito-
chondria are endowedwithmultiple Ca2+ transportmechanisms locat-
ed in the inner mitochondrial membrane (IMM) that mediates the
uptake and release of Ca2+ [1]. These include the mitochondrial Ca2+
uniporter (MCU) [8,9], as well as its regulatory protein, the EF hand-
containing protein termed MICU1 (for mitochondrial calcium uptake
1) [10]. Letm1 (leucine-zipper-EF hand-containing transmembranelycol bis[succinimidylsuccinate];
layer; RuR, Ruthenium red; STS,
pean Symposium on Calcium.
ces, Ben-Gurion University of
1336; fax: +972 8 6472992.
atz).
sevier B.V.region) was proposed to function in mitochondrial Ca2+/H+ exchange
[11]. However, other functions, such as in mitochondrial K+ homeosta-
sis, have been proposed such that the contribution of Letm1 to Ca2+
transport has been questioned [12]. The Na+/Ca2+ exchanger superfam-
ily member NCLX serves as themajor agent of Ca2+ efﬂux [13].While all
these Ca2+ transport systems mediate the transport of Ca2+ across the
inner mitochondrial membrane (IMM), Ca2+ must ﬁrst cross the outer
mitochondrial membrane (OMM) before being transported across the
IMM. To date, the only identiﬁed protein mediating Ca2+ transport in
the OMM is the voltage-dependent anion channel 1 (VDAC1) [14].
Accordingly, VDAC1 is permeable to Ca2+ [14–16] and possesses
Ca2+-binding sites [14,17,18].
Located in the OMM, VDAC1 assumes a crucial position in the cell,
serving as the main interface betweenmitochondrial and cellular metab-
olisms, controlling cross-talk between mitochondria and the rest of the
cell [19]. VDAC1 serves as a controlled passage for anions, Ca2+ and
other cations, adenine nucleotides and other metabolites into and out of
mitochondria, thus playing a crucial role in regulating the metabolic and
energetic functions of mitochondria. In addition, VDAC1 functions as an
anchor point formitochondria-interacting proteins [19] and is also recog-
nized as a key protein in mitochondria-mediated apoptosis, participating
in the release of apoptotic proteins and interacting with anti-apoptotic
proteins [19].
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chondrial inter-membrane space [14]. Permeability of the VDAC1 channel
to Ca2+ was demonstrated upon reconstitution of the puriﬁed protein
into a planar lipid bilayer [14,16]. In addition, La3+ [14], ruthenium red
and AzRu [14,17,20], all of which compete with Ca2+ for binding sites
in various proteins, are capable of inhibiting VDAC1-mediated Ca2+
conductivity in the lipid bilayer-reconstituted system. Finally, it
was shown that Ca2+ regulates the uptake of Ca2+ into VDAC1-
reconstituted liposomes [21] and that over-expression of VDAC1
in HeLa cells and skeletal myotubes enhances the transfer of Ca2+
into mitochondria [15].
Several lines of evidence suggest that VDAC1 possesses Ca2+-binding
site(s) [14,17,18]. Firstly, RuR [14], ruthenium amine binuclear complex
(Ru360) [22] and AzRu, a recently-synthesized photoactivatable reagent
[20], all able to speciﬁcally interact with several Ca2+-binding proteins,
decrease VDAC1 channel conductance in a time-dependent manner
and stabilize the channel in the closed state. Such decrease in conduc-
tance can be prevented by Ca2+ [23], strongly suggesting that RuR and
Ca2+ share a common binding site(s) or recognize the same VDAC1
conformation. Likewise, AzRu was also found to interact with VDAC1
and decrease channel conductance, an effect that was prevented by
Ca2+ but not by Mg2+, again suggesting interaction of AzRu with the
VDAC1 Ca2+-binding site(s) or a deﬁned protein conformation [23].
RuR [17,24], like AzRu [23], had no effect on mutated E72Q- or E202Q-
VDAC1 channel conductance, with [103Ru]AzRu labeling native but not
mutated VDAC1, suggesting that mutation of these residues stabilizes a
VDAC1 conformation that doesn't bind RuR and AzRu, or alternatively,
that their interaction with this conformation does not modify VDAC1
conductance.
RuRwas found to protect against cell death induced by variousmeans
[24–28]. Furthermore, RuR and AzRu protected against apoptosis induced
in T-REx-293 cells expressing native but not E72Q- or E202Q-mutated
VDAC1 [23,24]. RuR did not interact with E72Q-VDAC1 to reduce its
channel activity or protect against apoptosis in cells expressing this
mutant [17]. RuR- and AzRu-mediated protection against cell death, as
induced by several apoptotic stimuli [24–29], may arise from interaction
with a VDAC1 Ca2+-binding site or with a speciﬁc protein conformation
or by inhibiting mitochondrial Ca2+ transport. These ﬁndings also
indicate that VDAC1 functions as a Ca2+-sensitive Ca2+ transporter in
the OMM.
Mitochondrial Ca2+ is involved both in physiological and patho-
physiological conditions [30]. Non-physiological Ca2+ overload depolar-
izes mitochondria by opening the permeability transition pore (PTP),
with concomitant release of cytochrome c (Cyto c) and other IMS-
located proteins, leading to both apoptotic and necrotic cell death, condi-
tions associated with disease pathogenesis [31–33]. It is now well
demonstrated that local Ca2+ transfer between adjacent domains of the
sarco/endoplasmic reticulum (ER/SR) and mitochondria permits Ca2+
release from the ER/SR, leading to an enhancement of mitochondrial
Ca2+ uptake and evoking an increase in matrix [Ca2+] [34–36]. Release
of Ca2+ from the ER via inositol-1,4,5-trisphosphate receptors (IP3Rs)
has been observed inmodels of apoptosis and has been directly implicat-
ed in mitochondrial Ca2+ overload [37]. The speciﬁc sites of physical
association between the ER and mitochondria, known as mitochondria-
associated membranes (MAMs), include high levels of VDAC1, among
other proteins [38,39]. It has been recently established that VDAC1 (but
not VDAC2 or VDAC3) selectively interactswith IP3Rs and is preferentially
involved in the transmission of low-amplitude apoptotic Ca2+ signals to
mitochondria [40]. The involvement of VDAC1 in ER-mitochondria Ca2+
cross-talk places VDAC1 at a central position on the route transferring
Ca2+ signals from the ER to the mitochondria, and thus couples ER and
mitochondrial functions [40].
Although changes inmitochondrial Ca2+ concentration are known to
trigger apoptosis, themitochondrial target for Ca2+-mediated activation
of Cyto c release and the precise mechanism are not known. Substantial
evidence, however, suggests that VDAC1 may play a role in this process.Recently, we proposed that Cyto c release from the mitochondria is
mediated via a central pore formedwithin a VDAC1 oligomeric structure,
creating a pathway large enough for passage of a folded protein, such as
Cyto c. We demonstrated that VDAC1 oligomerization is coupled to Cyto
c release and apoptotic cell death, as induced by various stimuli [41–45].
While apoptosis inducers stimulated VDAC1 oligomerization, the apo-
ptosis inhibitor, 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS),
prevented STS-induced VDAC1 oligomerization and apoptosis [42,44].
In addition, VDAC1 oligomerization occurs upstream of caspase activa-
tion [42]. These results clearly indicate VDAC1 to be a component of
the apoptosis machinery and support the suggestion that VDAC1 oligo-
merization is coupled to apoptosis induction.
In this study, the effect of alterations in cellular Ca2+ homeostasis on
VDAC1 oligomerization and apoptosis induction was studied. We show
that various apoptosis stimuli increase intracellular [Ca2+] and VDAC1
oligomerization. Moreover, increasing intracellular [Ca2+]i using a
Ca2+ ionophore or thapsigargin resulted in VDAC1 oligomerization,
whereas decreasing [Ca2+]i using the chelator BAPTA-AM inhibited
both VDAC1 oligomerization and apoptosis induction. Finally, we dem-
onstrate that the Ca2+ ionophore A23187 and thapsigargin enhanced
VDAC1 expression levels. The results suggest that VDAC1 oligomeriza-
tion, and thus apoptosis, are regulated by cellular Ca2+ levels.
2. Materials and methods
2.1. Materials
Arsenic (III) oxide (As2O3), calcium chloride dehydrate, carboxy-
methyl (CM)-cellulose, n-decane, dimethyl sulfoxide (DMSO), carbonyl
cyanide p-triﬂuoromethoxyphenylhydrazone (FCCP), Hepes, leupeptin,
mannitol, phenylmethylsulfonyl ﬂuoride (PMSF), propidium iodide, soy-
bean asolectin, staurosporine (STS), sucrose, tetramethylrhodamine-
methyl ester (TMRM), thapsigargin (TG) and Tris were purchased from
Sigma (St. Louis, MO). Lauryl-(dimethyl)-amine oxide (LDAO) was
obtained from Fluka (Buchs, Switzerland). Hydroxyapatite (Bio-Gel
HTP) was purchased from Bio-Rad (Hercules, CA) and celite comes from
Merck (Darmstadt, Germany). Coelenterazine (DeepBlueC [DBC]) was
obtained fromBioline (Taunton,MA).Monoclonal anti-VDAC1 antibodies
produced against the N-terminal region of 31HL human porin came from
Calbiochem-Novobiochem (Nottingham, UK). Ethylene glycolbis
(succinimidylsuccinate) (EGS) was obtained from Pierce. Rabbit
polyclonal antibodies against VDAC1 amino acids 150–250 came
from Abcam (Cambridge, UK). Monoclonal antibodies against actin
were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Horseradish peroxidase (HRP)-conjugated anti-mouse antibodies
were obtained from Promega (Madison, WI). Annexin V (FITC) was
from Enzo Life Sciences (Lausen, Switzerland), BAPTA-AMwas obtained
from Tocris Bioscience (Bristol, UK), Fluo-4-AM was obtained from
Invitrogen (Grand Island, NY), dihydro-rhodamine-2-acetylmethyl
ester (Rhod-2-AM) was from Teﬂabs (Austin, Texas), and siRNA was
purchased fromDharmacon (Lafayette, CO). JetPRIMEwas fromPolyPlus
Transfection (Illkirch, France). Hank's balanced salts solution (HBSS)
without calcium, magnesium and phenol red, Dulbecco's modiﬁed
Eagle's medium (DMEM) growth media, and the supplements fetal calf
serum, L-glutamine, penicillin-streptomycin, were obtained from Biolog-
ical Industries (Beit Haemek, Israel).
2.2. Cell growth and transfection
T-REx-293 (transformed primary human embryonal kidney) or HeLa
(human cervical adenocarcinoma) cells were maintained in DMEM
supplemented with 10% fetal calf serum (1% or 0% fetal calf serum
when conducting ionomycin or thapsigargin treatments, respectively),
2 mM L-glutamine, 1000 U/ml penicillin and 1 μg/ml streptomycin and
maintained in a humidiﬁed atmosphere at 37 °C with 5% CO2.
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Fluo-4-AMwasused tomonitor changes in cytosolic Ca2+ levels. HeLa
cells (1 × 106 cells/ml) were harvested after the appropriate treatment,
collected (1500 × g for 10 min), washed with HBSS buffer (5.33 mM
KCl, 0.44 mM KH2PO4, 138 mM NaCl, 4 mM NaHCO3, 0.3 mM Na2HPO4,
5.6 mM glucose, 0.03 mM phenol red) supplemented with 1.8 mM
CaCl2 (HBSS+) and incubated with 2.5 μM Fluo-4 in 200 μl HBSS(+)
buffer in the dark for 30 min at 37 °C. After washing the remaining dye,
the cells were incubated with 200 μl HBSS(+) buffer and changes
in cellular free Ca2+concentration were measured immediately via
ﬂuorescence-activated cell sorter (FACS) analysis. At least 10,000
events were recorded on the FL1 detector, represented as a histogram,
and analyzed by the FACSCalibur ﬂow cytometer software (BD Biosci-
ences, Franklin Lakes, NJ). Positive cells showed a shift to an enhanced
level of green ﬂuorescence (FL1). Changes in cellular Ca2+ were moni-
tored in live cells using the high content Operetta screening system
(Perkin-Elmer, Hamburg, Germany). In eachwell, tenﬁeldswere imaged
using a 20×wide ﬁeld objective and excitation ﬁlter of 520–550 nmand
emission ﬁlter of 560–630 nm.
Changes in mitochondrial Ca2+ were monitored in live cells using
Rhod-2-AM, a compound that undergoes enhancement of ﬂuorescence
upon binding to Ca2+ and accumulates in the mitochondria [46], with
mitochondrialmembrane potential serving as the driving force. It should
be noted that Rhod-2 staining is not exclusive to mitochondria and also
appears in the cytosol. HeLa cells were seeded in a 96-well plate, treated
with TG or As2O3, incubated at 37 °C for 30 minwith orwithoutmedium
containing 20 μM FCCP. The cells were incubated at 37 °C for 30 min in
HBSS(+) containing 1 μM Rhod-2-AM and washed twice with
HBSS(+). Finally Rhod-2 ﬂuorescencewas analyzed using a plate reader.
Rhod-2 ﬂuorescence sensitivity to FCCP reﬂects mitochondrial Ca2+
accumulation. FCCP is a proton ionophore that dissipates the mitochon-
drial membrane potential (ΔΨ), the driving force for Rhod-2 uptake by
the mitochondria. Thus, in cells not treated with FCCP, the ﬂuorescence
signal reﬂects both cytosolic and mitochondrial [Ca2+] levels, while in
cells treated with FCCP, the ﬂuorescence signal reﬂects the Rhod-2
background or/and cytosolic [Ca2+].
2.4. Chemical cross-linking
T-REx-293 or HeLa cells (1.5 to 3 mg/ml in PBS, pH 8.2) were
harvested after the appropriate treatment and incubated with the
cross-linking reagent EGS (150–300 μM) for 15 min at 30 °C. Samples
(60 to 90 μg) were subjected to SDS-PAGE and immunoblotting using
N-terminal-directed anti-VDAC1 antibodies, as described below. Quanti-
tative analysis of immune-reactive VDAC1 dimer bands was performed
using Image Gauge software (version 4.0; Science Lab 2001) provided
by Fujiﬁlm.
2.5. Mitochondrial membrane potential determination
Mitochondrial membrane potential (ΔΨ) was determined using
TMRM, a potential-sensitive dye, and a plate reader. HeLa cells were
treated with ionomycin and subsequently incubated with TMRM
(1 μM, 20 min). Cells were then washed twice with PBS and examined
in the plate reader. FCCP-mediated ΔΨ dissipation served as a control.
2.6. Apoptosis analysis
T-REx-293 or HeLa cells (2 × 105), untreated or treated with BAPTA-
AM, ionomycin or other reagents, were analyzed for apoptotic cell death
using propidium iodide (PI), annexin V-ﬂuorescein isothiocyanate (FITC)
and ﬂow cytometer analysis. Cells were collected (1500 × g for 10 min),
washed, and resuspended in 200 μl binding buffer (10 mM HEPES/
NaOH, pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2). Annexin V–FITC was
added according to the recommended protocol, and the cells wereincubated in the dark for 15 min. Cells were then washed once with
binding buffer and resuspended in 200 μl binding buffer, to which PI
was added immediately before ﬂow cytometry analysis. At least 10,000
events were collected, recorded on a dot plot, and analyzed by the
FACSCalibur ﬂow cytometer software (BD Biosciences).
2.7. Gel electrophoresis and immunoblotting
SDS-PAGE was performed according to Laemmli [47]. Gels were
stained with Commasie Brilliant Blue or electro-transferred onto nitro-
cellulose membranes for immunostaining. Membranes containing the
transferred proteins were blocked with 5% non-fat dry milk and 0.1%
Tween-20 in Tris-buffered saline and incubated with monoclonal anti-
VDAC1 antibodies (1:10,000), followed by incubation with HRP-
conjugated anti-mouse IgG secondary antibodies (1:10,000). After treat-
ment with the appropriate primary and secondary antibodies, enhanced
chemiluminescence (Pierce, Rockford, IL) was performed.
2.8. VDAC1 channel conductance measurement
VDAC1 was puriﬁed from sheep liver mitochondria following LDAO
solubilization and chromatography using hydroxyapatite resin and
CM-cellulose [18]. Single and multiple channel current recording and
data analysis were carried out as described previously [14]. Brieﬂy, a
planar lipid bilayer (PLB)was prepared from soybean asolectin dissolved
in n-decane (30 mg/ml). Puriﬁed VDAC1 was added to the cis chamber
containing 1 M NaCl or 150 mM CaCl2 and 10 mM Hepes, pH 7.4. After
one or several channels were inserted into the PLB, excess protein was
removed by perfusing the cis chamber with ~20 volumes of solution to
prevent further channel incorporation. Recordings were made under
voltage clamp using a Bilayer Clamp BC-535B ampliﬁer (Warner
Instruments, Hamden, CT). Currents were measured with respect to
the trans side of the membrane (ground). The currents were low pass-
ﬁltered at 1 kHz and digitized on-line using a Digidata 1440-interface
board and pClampex 10.2 software (Axon Instruments, Union City, CA).
The effects of RuR and AzRu, added to the cis chamber, on channel
conductance were carried out as above in 1 M NaCl, with recordings
taken before and after RuR and AzRu addition.
3. Results
We have shown that apoptosis inducers, such as STS, selenite and
cisplatin, acting via different mechanisms, all induced VDAC1 oligomeri-
zation [42]. Since these agents are also known to disrupt Ca2+homeosta-
sis, we investigated here whether Ca2+ is the common signaling
molecule leading to VDAC1 oligomerization.
3.1. Ca2+ is required for VDAC1 oligomerization and apoptosis
To assess the requirement of Ca2+ for VDAC1 oligomerization, HeLa or
T-REx-293 cellswere pre-incubatedwith the cell-permeable Ca2+ chelat-
ing reagent, BAPTA-AM(acetoxymethyl ester formof bis(aminophenoxy)
ethan -N,N,N′,N′-tetraacetic acid), which is cleaved by intracellular
esterases to release the free acid form that subsequently decreases the
intracellular Ca2+ concentration. Pre-incubation of cells with BAPTA-AM
resulted in a signiﬁcant inhibition of both selenite-induced VDAC1 oligo-
merization (Fig. 1A, B) and apoptotic cell death (Fig. 1C).
Next, to test the effect of elevating [Ca2+]i on VDAC1 oligomerization,
the Ca2+ ionophore ionomycin was used to increase cellular Ca2+ levels
and to allow for re-equilibration of Ca2+ gradients between mitochon-
dria, cytosol and the extracellular space [48,49]. Ionomycin treatment is
frequently used as a model of Ca2+-dependent cell death, as this
ionophore can induce both necrotic and apoptotic cell death [50,51]. In-
cubation of cells with ionomycin resulted in amarked increase in VDAC1
oligomerization (Fig. 2A), as well as in apoptotic cell death (Fig. 2B). In
addition, an anti-VDAC1 antibody-labeled protein band that migrated
Fig. 1. BAPTA-AM, a Ca2+-chelating reagent, prevents VDAC1 oligomerization. HeLa (A) or T-REx-293 (B) cells were incubated with BAPTA-AM (20 μM, 1.5 h) and then with or
without selenite (25 μM, 2.5 h), harvested, cross-linked with EGS (250 μM, 15 min), and analyzed by immunoblotting using anti-VDAC antibodies. (C) Apoptotic cell death induced
by the different treatments was assayed using annexin V–FITC, PI staining and FACS analysis. Results are representative of two similar experiments.
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ptosis induction and EGS treatment (asterisk in Fig. 2A). This band
appeared only when apoptosis was induced and most likely represents
a monomer that underwent conformational changes that were ﬁxed
upon intermolecular cross-linking, thereby modifying its mobility in
SDS-PAGE.
As expected, ionomycin increased Ca2+ intracellular levels, as
monitored using Fluo-4 and FACS analysis (Fig. 2C).
Increase in intracellular Ca2+ was also induced using thapsigargin,
an inhibitor of the sarcoplasmic reticulum/ER Ca2+-ATPase that dis-
rupts the homeostatic balance of [Ca2+]i and induces ER stress [52].
Thus, the effects of thapsigargin on VDAC1 oligomerization and apo-
ptotic cell death were also evaluated. Incubation with thapsigargin
resulted in an increase in [Ca2+]i, apoptosis and induced an increase
in VDAC1 oligomerization (Fig. 3).Fig. 2. VDAC1 oligomerization and apoptosis are enhanced by ionomycin. HeLa cells were incuba
of VDAC1oligomerization (A). Apoptotic cell death and TMRMﬂuorescence (ΔΨ)were analyzed
of [Ca2+]i levels in control cells and in cells treated with ionomycin, as monitored using Fluo-4 a3.2. Apoptotic stimuli elevate intracellular Ca2+ levels and encourage
VDAC1 oligomerization
Next,we examinedwhether induction of apoptosis by agents that are
known to affect intracellular Ca2+ is associatedwithVDAC1oligomeriza-
tion. Thapsigargin, STS, selenite and other apoptosis inducers were
shown to induce apoptotic cell death and disrupt Ca2+ homeostasis
[53]. Incubation of HeLa cells with STS, selenite or As2O3 resulted in
elevated intracellular Ca2+ levels, as monitored using Fluo-4 and FACS
analysis (Fig. 4A and B) or by cell imaging using the Operetta system
(Fig. 4C). Some images show highly intense ﬂuorescent punctuations,
which may represent mitochondria. As shown previously [42], these
apoptosis stimuli induced apoptotic cell death (Fig. 4D) and VDAC1
oligomerization, as revealed using chemical cross-linking followed by
Western blotting with anti-VDAC1 antibodies (Fig. 4E). Several anti-ted with the indicated concentrations of ionomycin (1–5 μM, 45 min), followed by analysis
as a function of ionomycin concentration (B). [Ca2+]i levels (C). Representative FACS analysis
nd FACS analysis. The values shown indicate the increase in [Ca2+]i.
Fig. 3. Thapsigargin induces VDAC1 oligomerization. HeLa cells were incubated with the indicated concentrations of thapsigargin (TG) for 18 h, followed by analysis of VDAC1 olig-
omerization (A), apoptotic cell death (dark gray column) and intracellular Ca2+ levels (light gray column) (B), as described in the legend to Fig. 2. Note the increase in VDAC1 levels
upon TG treatment. Low expo indicates a short time of exposure to the ﬁlm.
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the apoptosis stimuli and found to correspond to VDAC1 dimers, trimers,
tetramers and multimers. The appearance of the intramolecular cross-
linked monomeric VDAC1 species was also obtained upon apoptosis
induction and EGS treatment (asterisk in Fig. 4E).
These results thus clearly demonstrate that strong association
exists between the level of apoptosis, the extent of [Ca2+]i increase
and the degree of VDAC1 oligomerization.
3.3. VDAC1 Ca2+ permeability and Ca2+-binding sites function in the
oligomerization of the protein
The effect of Ca2+ on VDAC1 oligomerization can bemediated via the
transport or binding of Ca2+ to VDAC1. Since VDAC1 allows passage of
both cations and anions, its permeability to Ca2+ can be estimated
from the reversal potential determined upon encountering different
CaC12 concentration gradients [14]. As such, VDAC1 channel conduc-
tance was analyzed in a gradient of 150–500 mM CaCl2 as a function of
voltage, generating a proﬁle in the form of ramp (Fig. 5A). The reverse
potential of 10.3 mV obtained under these conditions was used to esti-
mate the permeability ratio of PCa2+/PCl− (Fig. 5A) [14]. The obtained
ratio of 0.36 indicates that VDAC1 permeability to Ca2+ is only
2.8-times less than that to Cl−. This value is similar to a previously
reported value [14] and indicates that VDAC1 is highly permeable to
Ca2+. The channel conductance in the presence of CaCl2, as with NaCl,
is voltage-dependent, decreasing at highly negative or positive voltages
(Fig. 5B).
RuR and AzRu decreased VDAC1 channel conductance at all tested
voltages (Fig. 5C) in a manner that can be prevented by Ca2+ [14,20].
RuR and AzRuwere shown to inhibit the channel activity of recombinant
wild type but not of mutated VDAC1 [17], suggesting that VDAC1 pos-
sesses Ca2+-binding sites. In addition, these reagents inhibit mitochon-
drial Ca2+ transport [14,20] and protect against apoptosis in T-REx-293
cells expressing native but notmutated VDAC1 [17,20,23,24]. Theseﬁnd-
ings suggest that RuR and AzRu interact with VDAC1 to mediate their
anti-apoptotic activities. Thus, to evaluate the effects of AzRu on VDAC1
oligomerization induced by STS, cells were pre-incubated with AzRu,
followedby incubationwith STS (Fig. 5D). AzRu inhibition of VDAC1olig-
omerization points to the involvement of mitochondrial Ca2+ in VDAC1
oligomerization.
3.4. Mitochondrial Ca2+ and VDAC1 oligomerization
Mitochondrial Ca2+ overload has been shown to lead to a dissipation
of the mitochondrial potential (mΔΨ), the opening of the permeability
transition pore and the release of cytochrome c [21,31]. Therefore, toverify whether ionomycin also increased mitochondrial Ca2+ levels,
mΔΨwasmeasuredusing TMRM. Such analysis revealed that ionomycin
indeed decreased mΔΨ and concomitantly enhanced apoptotic cell
death (Fig. 2B).
To further demonstrate that VDAC1 oligomerization involves mito-
chondrial [Ca2+], we used the ﬂuorescent dye, Rhod-2-AM. Rhod-2 ﬂuo-
rescence was analyzed in cells subjected to apoptosis induced by As2O3
or thapsigargin, using a plate reader (Fig. 6A). To distinguish between
mitochondrial and cytosol-derived signals, before loading with
Rhod-2-AM, the cells were treated with FCCP to dissipate mΔΨ and
thus, the driving force for mitochondrial Ca2+ accumulation. Cells treat-
ed with thapsigargin or As2O3 showed an increased FCCP-sensitive
Rhod-2 ﬂuorescent signal (Fig. 6A), reﬂecting an increase in [Ca2+]m.
Next, to further evaluate the function ofmitochondrial Ca2+ in VDAC1
oligomerization, we tested the effect of mΔΨ dissipation by FCCP on
VDAC1 oligomerization as induced by ionomycin and thapsigargin. We
found that even in the presence of FCCP, ionomycin induced VDAC1 olig-
omerization (data not shown). This is not surprising as decreasing the
mΔΨ by FCCP would not prevent Ca2+ entry into the mitochondria via
ionomycin, since ionomycin allows for equilibration of cytosolic and the
mitochondrial Ca2+ levels. Thapsigargin, on the other hand, would
increase cytosolic but not mitochondrial Ca2+ in the presence of FCCP.
VDAC1 oligomerization, as induced by thapsigargin, is reduced in the
presence of FCCP (Fig. 6B), which decreased similarly the mΔΨ (mea-
sured with ΤΜΡΜ) in the absence and the presence of thapsigargin
(data not shown). These results suggest that mitochondrial Ca2+ is
important for induction of VDAC1 oligomerization.
3.5. Increased intracellular Ca2+ levels induce VDAC1 over-expression
To examine whether intracellular Ca2+ also affects VDAC1 protein
levels, we followed VDAC1 expression in cells treated with the Ca2+
ionophore A23187. It was found that incubation of HeLa cells with
A23187 results in increased VDAC1 protein levels (Fig. 7A and B). An
increase in VDAC1 expression was also obtained when [Ca2+]i was
enhanced with thapsigargin (see Fig. 3), increasing VDAC1 level
by 2.7- and 4.1-fold upon exposure to 10 and 20 μM of thapsigargin,
respectively (Fig. 7C).
4. Discussion
4.1. Ca2+ overload signals VDAC1 oligomerization and apoptosis
Anti-cancer drugs and cytotoxic agents, such as thapsigargin, STS,
As2O3 and selenite and, reagents that induce apoptotic cell death,
were also shown to disrupt cell Ca2+ homeostasis [53], all shown here
Fig. 4. Apoptosis inducers elevate intracellular Ca2+ levels and induce VDAC1 oligomerization. HeLa cells were incubated for 22 h with selenite (8 μM), As2O3 (20 μM) or STS
(0.5 μM), harvested and intracellular Ca2+ levels (A, B, C) apoptotic cell death (D) and VDAC1 oligomerization (E) were assessed. A. Representative FACS analysis of [Ca2+]i levels,
determined using Fluo-4 and FACS. B. Quantitative analysis of [Ca2+]i, as assessed by FACS (data from panel A) (n=3). C. HeLa cells were plated on black CellCarrier 96-wells plates
overnight, and then treated for 22 h with selenite (6 μM), As2O3 (10 μM) and STS (0.5 μM), followed by incubation with Fluo-4. Cell ﬂuorescence was recorded using the Operetta
and representative images are shown. D. Quantitative analysis of apoptosis, as measured by FACS analysis (using annexin V–FITC and PI staining) (n=3). E. VDAC1 oligomerization
revealed using EGS-based cross-linking. Cells (2.5 mg/ml) were washed with PBS, pH 8.3 and incubated with EGS (250 μM) at 30 °C for 15 min and then subjected to SDS-PAGE and
immunoblotting using anti-VDAC1 antibodies. The positions of VDAC1 monomers to multimers are indicated. The asterisks indicate an anti-VDAC1 antibody-labeled protein band
that migrates below the position of monomeric VDAC1.
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with [Ca2+]i signaling includes an elevation of [Ca2+]i by increasing
Ca2+ uptake from the extracellular space in some tumor cells, asin the case of cisplatin, or triggering Ca2+ release from stores that con-
sequently encourages apoptosis, as in the case of As2O3 [53]. However,
As2O3 toxicity is not limited to [Ca2+]i disturbances, as it can also elicit
Fig. 5. VDAC1 is a Ca2+-permeable channel and its conductance is inhibited by RuR and AzRu. Sheep liver mitochondria-puriﬁed VDAC1 was reconstituted into a PLB and recording
of channel conductance was carried out as described previously [14]. A. Currents through VDAC1 obtained in response to voltage ramps (−60 to +60 mV, at 1 mV/ms) in the pres-
ence of a CaCl2 concentration gradient (150–500 mM) were recorded. The broken line indicates the zero current level, arrowheads indicate the channel in a sub-conducting states
and the arrow indicates the reversal potential (Vrev). B. Multi-channel recordings of the average steady-state conductance of VDAC1 in the presence of a symmetric CaCl2 concen-
tration (150 mM) (□) or NaCl (0.5 M) (■), as a function of voltage. Relative conductance was determined as the ratio of conductance at a given voltage to maximal conductance. C.
The effects of RuR and AzRu on VDAC1 conductance were measured in symmetric 1 M NaCl solution on both sides of the bilayer as a function of voltage, ranging from 60 mV to−
60 mV. The average steady-state conductance at a given voltage was normalized to the conductance at 10 mV. The recordings were taken before (•) and 10 min after the addition of
RuR (50 μM) (○) or 30 min after the addition AzRu (50 μM) (o). D. AzRu-mediated inhibition of VDAC1 oligomerization. HeLa cells were incubated with the indicated concentra-
tions of AzRu (16 h), followed by incubation with or without STS (4 μM for 3.5 h). The cells were then harvested, cross-linked with EGS (300 μM, 15 min), and analyzed by immu-
noblotting using anti-VDAC1 antibodies. Di indicates VDAC1 dimers, while the numbers at the bottom indicate the percentage of dimers formed. The intensities of the dimer bands
are given as dimer percentage relative to the maximal dimer intensity obtained in STS treatment.
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include protein kinase C (PKC) activation, mitochondrial depolariza-
tion, depletion of intracellular glutathione, up-regulation of caspase-
3, down regulation of Bcl-2, and Bax/Bak-dependent Cyto c release
[54–57]. Thapsigargin decreases the ER Ca2+ pool by inhibiting SERCA
pumps, causing a transient increase in [Ca2+], resulting in ER stress and
apoptosis [58]. Itwas reported that thapsigargin induced apoptosis in sev-
eral tumor cell lines [59,60], with its effect being attributed to a reductionFig. 6.Mitochondrial Ca2+ is increased upon apoptosis induction. HeLa cells were challengedwi
(20 μM, 30 min) and treated with Rhod-2-AM (1 μM, 30 min). Cellular ﬂuorescence was analy
FCCP-sensitive signal being presented. B. HeLa cells were incubated with FCCP (5 μM, 30 min) an
by EGS (60 μM, 1 mg protein/ml) cross-linking as described in Fig. 1. The intensities of the dimeof the mitochondrial transmembrane potential and a concomitant in-
crease in ROS generation [61]. STS, an ATP-competitive inhibitor of PKC,
PKA, PKG, p60v-src tyrosineprotein kinase andCaMkinase II [62], directly
provokes Ca2+ leak from the ER by activating caspase-3-mediated cleav-
age of IP3R1 [63]. STSwas shown to signiﬁcantly increase [Ca2+]i [64] and
promote the activation of the mitochondrial Ca2+-dependent protease,
calpain [65]. Selenite treatment induced apoptosis, as well as causing a
rapid increase in cytosolic [Ca2+] and accumulation of ROS [66,67].th thapsigargin (TG, 10 μM, 30 min) or As2O3 (50 μM, 3 h), incubated with or without FCCP
zed using a plate reader. Results are representative of two similar experiments, with the
d then challenged with TG (40 or 60 μM, 90 min) and VDAC oligomerization was analyzed
r bands are given relative (RU) to dimer intensity in a sample not treated with FCCP or TG.
Fig. 7. Ca2+ overload induces up-regulation of VDAC1 expression. HeLa cells were incubated with the indicated concentration of A23187 for 24 h (A, B) or with thapsigargin (TG)
for 18 h (C, D). Thereafter, VDAC1 expression levels were analyzed by immunoblotting (A, C). Quantitative analysis of VDAC1 expression is shown in (B, D).
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sis inducers discussed above was also demonstrated in the current
study (Fig. 4). These apoptosis stimuli also induced VDAC1 oligomeriza-
tion [41–44] (Fig. 4), suggesting a link between an increase in [Ca2+]i,
VDAC1 oligomerization and apoptosis induction. This is further supported
by our demonstration that an increase in [Ca2+]i, induced by Ca2+
ionophores (Fig. 2) or thapsigargin (Fig. 3), leads to VDAC1 oligomeriza-
tion and apoptosis induction. Conversely, BAPTA-AM-mediated decrease
in [Ca2+]i inhibits VDAC1 oligomerization and prevents apoptosis
induction (Fig. 1). Thus, it is possible that the commonmechanism shared
by all agents inducing apoptosis and enhancing VDAC1 oligomerization
involves disrupting [Ca2+]i homeostasis by increasing [Ca2+]i.
The dynamic equilibrium between VDAC1 monomers and oligomers
can be inﬂuencedby [Ca2+]i. However, it is not clearwhether cytosolic or
mitochondrial Ca2+ ([Ca2+]m) mediates VDAC1 oligomerization, as
increased [Ca2+]i would lead to an increase in [Ca2+]m. In this respect,
we have shown that an increase [Ca2+]i, mediated by Ca2+ ionophore
(Fig. 2) was accompanied by a decrease in mΔΨ produced. This is in
accord with the ﬁndings that [Ca2+]m overload leads to a dissipation of
mΔΨ [21,31], although this decrease could also be a consequence of
the apoptotic cell death process. In addition, thapsigargin and As2O3
were found to increase the FCCP-sensitive Rhod-2 ﬂuorescent signal,
reﬂecting an increase in [Ca2+]m (Fig. 6A). Thus, Ca2+ ionophore
treatment increases both [Ca2+]i and [Ca2+]m, suggesting that
VDAC1 oligomerization may be induced by an increase in [Ca2+]m.
This is supported by the ﬁnding that VDAC1 oligomerization, as in-
duced by thapsigargin, was reduced in the presence of FCCP (Fig. 6B),
suggesting that mitochondrial Ca2+ is required. The inhibition of
VDAC1 oligomerization by AzRu, an inhibitor of mitochondrial Ca2+
transport [20] that directly interacts with VDAC1 and inhibits its channel
conductance (Fig. 5C) and oligomerization (Fig. 5D), further points to
[Ca2+]m as being the regulator of VDAC1 oligomerization and apoptosis.
Ca2+ could mediate apoptosis via directly interacting with VDAC1,
able to transport Ca2+ across the OMM and also to bind Ca2+ [14,23].
Binding of Ca2+ to VDAC1, either from the cytosolic face or in the
mitochondrial inter-membrane space, can lead to an increase in VDAC1
oligomerization. However, [Ca2+]m may potentially affect VDAC1
oligomerization via a different mechanism that involves Cyto c. Not all
Cyto c is free, with a substantial portion instead being associated with
the anionic membrane lipid cardiolipin (CL). Thus, Cyto c dissociation
from CL is a prerequisite step for Cyto c release. This could be induced
by cardiolipin oxidation [68], by Ca2+ interaction with cardiolipin [69],
or by tBid [70]. It was also demonstrated that Cyto c encapsulated in
liposomes containing VDAC1 induced VDAC oligomerization [45]. Thus,
Ca2+-mediated dissociation of Cyto c from CL could lead to unbound
Cyto c activatingVDAC1oligomerization. Exploring the interplay between
mitochondrial Ca2+, VDAC1 oligomerization and apoptosis inductionwill
require further study.4.2. Ca2+ overload encodes information that up-regulates VDAC1
expression
In this study, we observed an increase in VDAC1 expression levels
upon increasing [Ca2+]i.. Cells exposed to thapsigargin or to the Ca2+
ionophoreA23187 (Fig. 7) resulted inup-regulation of VDAC1 expression.
This suggests that elevated cellular Ca2+ leads to increased VDAC1
expression. A23187 was shown to induce growth arrest and expression
of the DNA damage-inducible CCAAT/enhancer-binding protein
(C/EBP)-related gene, gadd153 [71].
Various studies demonstrated that Ca2+ activates signaling path-
ways that regulate gene transcription [72]. However, the exact signal
transduction mechanisms involved in transforming Ca2+ signals
into speciﬁc, ﬁnely controlled changes in gene expression have yet
to be fully delineated. Several reviews have addressed the variety
of regulatory mechanisms that participate in Ca2+-dependent gene
expression in neurons [73–75] and other cells [76,77]. There are
several potential Ca2+-dependent steps that could contribute to
the process of gene expression. Indeed, mRNA transcription, elonga-
tion, splicing, stability, and translation have all been suggested as
being regulated by Ca2+ [72].
The increase in VDAC1 expression level, as induced by an eleva-
tion of [Ca2+]i, may result from inhibition of VDAC1 degradation or
an increase in the level of VDAC1 mRNA. The mechanism(s) involved
in increased VDAC1 expression was not addressed here but will be
the subject of further research.
We propose that the increase in VDAC1 levels in the cell is associated
with apoptosis induction. VDAC1 over-expression was found to lead to
its oligomerization and apoptosis in the absence of any apoptosis stimuli
[24,78–80]. In addition, several apoptosis inducers, such as arbutin,
prednisolone, cisplatin, viral proteins, or UV irradiation, were found to
increase VDAC1 expression levels [81–87]. Thus, up-regulation of
VDAC1 expression may comprise a major mechanism by which these
treatments lead to cancer cell death. We further propose that the in-
crease in [Ca2+] induced by the various apoptotic signals (Figs. 2–4)
[53] leads to increased VDAC1 expression (Fig. 7), encouraging VDAC1
oligomerization and apoptosis induction.
To summarize, Ca2+ regulation of VDAC1 oligomerization and
apoptosis is a complex process and may involve several possible
mechanisms, from Ca2+-mediated dissociation of Cyto c from CL
leading to unbound Cyto c activating VDAC oligomerization, to up-
regulation of VDAC1 expression.Acknowledgements
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